Oncology & Cancer

FDA clears Avastin for late-stage cervical cancer

The Food and Drug Administration has approved Genentech's Avastin for a new use against late-stage cervical cancer, the sixth indication for the blockbuster biotech drug.

Medical research

Editing HPV's genes to kill cervical cancer cells

Researchers have hijacked a defense system normally used by bacteria to fend off viral infections and redirected it against the human papillomavirus (HPV), the virus that causes cervical, head and neck, and other cancers.

Oncology & Cancer

Why we should vaccinate boys against HPV as well as girls

Gillian Prue, from the School of Nursing and Midwifery at Queen's University of Belfast, says that the human papillomavirus (HPV) infection is common in men and can lead to genital warts and the development of some head and ...

Health

Researchers find moral beliefs barrier to HPV vaccine

A survey of first-year Grand Valley State University students showed the biggest barrier to receiving a Human Papillomavirus (HPV) vaccine was moral or religious beliefs, or a perceived promotion of sexual behavior, according ...

Oncology & Cancer

US OKs first-ever DNA alternative to Pap smear (Update 2)

U.S. government health regulators have cleared a genetic test from Roche as a first-choice screening option for cervical cancer. It was a role previously reserved for the Pap smear, the decades-old mainstay of women's health.

Oncology & Cancer

Pre-HPV vaccine, most oropharyngeal cancers HPV+

(HealthDay)—Most oropharyngeal cancers in the United States diagnosed between 1995 and 2005 were positive for human papillomavirus (HPV), specifically HPV 16 or 18, according to a study published in the May issue of the ...

page 27 from 40